PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB

NACompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 21, 2017

Study Completion Date

November 21, 2017

Conditions
Overactive Bladder
Interventions
DEVICE

NURO System PTNM Therapy

Trial Locations (11)

10016

NYU Urology Associates, New York

19104

Hospital of University of Pennsylvania, Philadelphia

27403

Alliance Urology Specialists, Greensboro

48123

Advanced Urogynecology of Michigan, P.C., Dearborn

53715

SSM Health Dean Medical Group, Madison

55125

Metro Urology, Woodbury

60201

NorthShore University Health System, Evanston

98101

Virginia Mason Medical Center, Seattle

33710-1925

Pinellas Urology, Inc., St. Petersburg

02138

Mount Auburn Hospital, Cambridge

07631

Urology Center Research Institute, LLC, Englewood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MedtronicNeuro

INDUSTRY